Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06371482
Status:
RECRUITING
Last Update Posted:
2024-06-17
First Post:
2024-03-27
Brief Title:
Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer Camel-01
Sponsor:
Hebei Medical University Fourth Hospital
Organization:
Hebei Medical University Fourth Hospital
Organization Data
Organization:
Hebei Medical University Fourth Hospital
Class:
OTHER
Study ID:
Camel-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hebei Medical University Fourth Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None